Drug Induced Lupus Erythematosus (DIL) | Medical Algorithm

Are you evaluating a patient for the diagnosis of drug-induced lupus erythematosus?

Yes

Did the patient's symptoms start after starting a medication?

Yes

Has the medication been implicated in causing drug-induced lupus?

Yes

Did the symptoms resolve within several weeks of discontinuing the drug?

Yes

Is the serum complement level normal?

Yes

Select an appropriate answer(s) for each clinical measure

Clinical findings

None

Skin rash

Fever

Photo-sensitivity

Arthritis

Pleurisy

Myalgias

Mouth sores

Hepatospleno-megaly

Fatigue

Anti-nuclear antibodies

None

Anti-histone (diffuse pattern)

Anti-double stranded DNA

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Number of key findings

Number of additional common findings

Does the patient have drug-induced lupus erythematosus?

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
Clinical Diagnosis, Including Family History For Genetics
Imaging Studies
Laboratory Tests
Other Testing
- Clinical Features of Acute Lupus Pneumonitis
Criteria For Diagnosis
Severity, Prognosis, Stage
Complications
- Systemic Lupus Erythematosus (SLE) | Moyamoya Syndrome
Differential Diagnosis And Mimics, Red Flags

Therapy

Pharmacogenetics
- SELENA Flare Tool
- Shrinking Lungs Syndrome (SLS) | Systemic Lupus Erythematosus
Drug Interactions
- SELENA Flare Tool
Prevention
Interventional Radiology

Monitoring

Drug Levels
- SELENA Flare Tool
Disease Progression
Complication Detection
Comorbid Conditions

Patient Concerns

Quality Of Life
Psychological Response

Evaluation

Results

Please fill out required fields.

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Therapy

Monitoring

Patient Concerns

Specialty

Objective

ICD-10

Diagnostic Features of Drug-Induced Lupus Erythematosus (DIL)

Purpose: To evaluate a patient for the diagnosis of drug-induced lupus erythematosus.

Evaluation

Results

Please fill out required fields.

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Therapy

Monitoring

Patient Concerns

Specialty

Objective

ICD-10